FDA Extends Comment Period on Medical User Fee Program
The Food and Drug Administration is extending to November 1, 2010, the comment period for the notice that appeared in the August 13, 2010 Federal Register, in which FDA requested input and comments from interested stakeholders on FDA’s medical user…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program.